search
Back to results

Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

Primary Purpose

Sarcoma, Cancer, Infectious Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Prevana Dressing
Standard Dry Gauze Dressing
Sponsored by
Medical University of South Carolina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Sarcoma

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age>18
  • Willing to consent to randomization and able to participate in the study
  • Lower extremity soft tissue sarcoma necessitating radiation prior to surgical resection
  • Primary closure of wound
  • Patients scheduled for surgical resection

Exclusion Criteria:

  • Flap coverage or skin graft
  • Patients scheduled for amputations as local control of their tumor
  • Sarcomas where radiation is not planned preoperatively
  • Repeat surgeries for oncologic reasons (positive margins)
  • Known allergy to adhesive tape

Sites / Locations

  • Medical University of South CarolinaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

NPWT dressing

Standard dry gauze dressing

Arm Description

Outcomes

Primary Outcome Measures

Wound Complication Rate
To estimate the wound complication rate of post-operative negative pressure dressings and traditional dry dressings, and risk of secondary interventions after resection of soft tissue sarcoma in lower extremities that have received pre-operative radiation.

Secondary Outcome Measures

Total Costs
To estimate the on total cost of care and resource utilization in patients treated with negative pressure wound therapy and traditional dry dressings.

Full Information

First Posted
December 15, 2015
Last Updated
April 24, 2023
Sponsor
Medical University of South Carolina
Collaborators
3M
search

1. Study Identification

Unique Protocol Identification Number
NCT02638298
Brief Title
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
Official Title
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds. A Prospective Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 2015 (undefined)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical University of South Carolina
Collaborators
3M

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a study comparing two methods of dressing a post operative wound that are currently in practice. One method is a traditional dry gauze dressing. The other method is using a negative pressure dressing that provides gentle suction on the wound. The investigators will attempt to determine how well the use of post-operative negative pressure dressing reduces wound healing problems in patients who have surgery after radiation for a sarcoma in the thigh or leg.
Detailed Description
Postoperative surgical site infections pose a significant challenge to the orthopaedic oncologist, especially in wounds that have been previously irradiated with neo adjuvant external beam radiation therapy (EBRT). There are many studies demonstrating the relatively high risk of wound complications after lower extremity sarcoma resection. Published data suggest that these preoperatively radiated wounds have a postoperative infection rate of 17%-44% with "traditional" dressings (e.g. dry gauze surgical dressings). A prospective series of 190 patients and showed a wound complication risk of 35% in preoperative irradiated wounds. The morbidity associated with wound complications can range from moderate (prolonged dressing changes) to severe (life or limb threatening infection). Patients who develop wound complications have been shown to longer hospitalizations and higher costs [ref]. Anatomic location of the tumor has been shown to be a risk factor for the development of wound complications with lower extremities being higher risk than upper extremities. There are several published studies examining the effect of negative pressure wound therapy (NPWT) on high risk surgical wounds. Abdominal wound complications can be reduced with the use of incisional NPWT. In the orthopaedic literature the use of negative pressure incisional dressings have been shown to lower the risk of wound complications in total hip arthroplasty, acetabular fractures, and extremity fractures. To our knowledge, there have not been any published studies on the utility of negative pressure wound therapy in previously irradiated soft tissue sarcoma wounds. The investigators feel that this high risk patient cohort could potentially benefit from reducing wound complications through NPWT and is an ideal population to study its effect.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcoma, Cancer, Infectious Disease

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
NPWT dressing
Arm Type
Experimental
Arm Title
Standard dry gauze dressing
Arm Type
Placebo Comparator
Intervention Type
Device
Intervention Name(s)
Prevana Dressing
Intervention Description
negative pressure wound therapy (NPWT) dressing
Intervention Type
Other
Intervention Name(s)
Standard Dry Gauze Dressing
Intervention Description
Standard Dry Gauze Dressing
Primary Outcome Measure Information:
Title
Wound Complication Rate
Description
To estimate the wound complication rate of post-operative negative pressure dressings and traditional dry dressings, and risk of secondary interventions after resection of soft tissue sarcoma in lower extremities that have received pre-operative radiation.
Time Frame
longitudinally up to 6 months postoperatively
Secondary Outcome Measure Information:
Title
Total Costs
Description
To estimate the on total cost of care and resource utilization in patients treated with negative pressure wound therapy and traditional dry dressings.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age>18 Willing to consent to randomization and able to participate in the study Lower extremity soft tissue sarcoma necessitating radiation prior to surgical resection Primary closure of wound Patients scheduled for surgical resection Exclusion Criteria: Flap coverage or skin graft Patients scheduled for amputations as local control of their tumor Sarcomas where radiation is not planned preoperatively Repeat surgeries for oncologic reasons (positive margins) Known allergy to adhesive tape
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jenna E Williams, MA
Phone
843-792-6639
Email
wiljenna@musc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lee R Leddy, MD
Organizational Affiliation
Medical University of South Carolins
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jenna E Williams, MA
Phone
843-792-6639
Email
wiljenna@musc.edu
First Name & Middle Initial & Last Name & Degree
Lee R Leddy, MD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data safety and monitoring will be provided by the Hollings Cancer Center DSMC. This committee will serve for all sites. The DSMC meets 6 times a year and reviews all MUSC IRB adverse events, protocol deviations/violations, early stopping rules and internal audit results. The PI will be responsible for identifying, reviewing monthly, and reporting adverse events. Individual participant data will not be shared between the sites. All data will be deidentified and linked with a code.

Learn more about this trial

Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

We'll reach out to this number within 24 hrs